Comparative effectiveness research in urology

World Journal of Urology

Volumn 29, Issue 3, 2011, Pages 277-282

  Wang, Amy T ^a   Wang, Jeffrey K ^a   Montori, Victor M ^a   Murad, Mohammad Hassan ^a  

^a MAYO CLINIC   (United States)

Author keywords

Comparative effectiveness research; Patient centered outcomes research; Urology

Indexed keywords

COMPARATIVE EFFECTIVENESS; EARLY DIAGNOSIS; ECONOMICS; HEALTH CARE COST; HUMAN; MALE; PATIENT CARE; PROSTATE TUMOR; REVIEW; UROLOGY;

COMPARATIVE EFFECTIVENESS RESEARCH; EARLY DETECTION OF CANCER; HEALTH CARE COSTS; HUMANS; MALE; PATIENT-CENTERED CARE; PROSTATIC NEOPLASMS; UROLOGY;

EID: 79957487159     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-010-0637-0     Document Type: Review

References (20)

1. Webster P (2010) Comparative effectiveness research stalls in the USA. Lancet 375(9712): 361-362.
2. IOM (Institute of Medicine) (2009). Initial National Priorities for Comparative Effectiveness Research. Washington, DC: National Academy Press; http://www. iom. edu/Reports/2009/ComparativeEffectivenessResearchPriorities. aspx. Accessed 8 Oct 2010.
3. US Department of Health and Human Services (2009) Report to the President and the Congress. http://www. hhs. gov/recovery/programs/cer/cerannualrpt. pdf Accessed 8 Oct 2010.
4. National Pharmaceutical Council (2010) The Patient-Centered Outcomes Research Institute Resource Guide. http://www. npcnow. org/Public/About_Us/Sitemap/Public/Research_Publications/Publications/pub_cer/The_Patient_Centered_Outcomes_Research_Institute_Resource_Guide. aspx. Accessed 10 Oct 2010.
5. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL (2008) Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 148(6): 435-448.
6. Wilt TJ, Brawer MK, Barry MJ, Jones KM, Kwon Y, Gingrich JR, Aronson WJ, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Fox S (2009) The Prostate cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer. Contemp Clin Trials 30(1): 81-87.
7. http://www. controlled-trials. com/ISRCTN20141297. The ProtecT trial. Evaluating the effectiveness of treatment for clinically localised prostate cancer 2007. ISRCTN Register. 11 J. Accessed 12 Oct 2010.
8. Dreyer NA, Tunis SR, Berger M, Ollendorf D, Mattox P, Gliklich R (2010) Why observational studies should be among the tools used in comparative effectiveness research. Health Aff 29(10): 1818-1825.
9. Wong YN, Nitra N, Hudes G, Localio R, Schwartz JS, Wan F, Montagnet C, Armstrong K (2006) Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA 296(22): 2683-2693.
10. Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S, Spangberg A, Busch C, Nordling S, Garmo H, Palmgren J, Adami HO, Norlen BJ, Johansson JE, Scandinavian Prostate Cancer Group Study, No. 4 (2005) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352(19): 1977-1984.
11. http://gold. ahrq. gov/projectsearch/grant_summary. jsp?grant=R01+HS19356-01. Comparative Effectiveness of Treatments for Localized Prostate Cancer (2010). Accessed 24 Nov 2010.
12. http://clinicaltrials. gov/ct2/show/study/NCT00756665. Prostate active surveillance study (PASS) 2010. Accessed 24 Nov 2010.
13. Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD, PLCO Project Team (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360(13): 1310-1319.
14. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A, ERSPC Investigators (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360(13): 1320-1328.
15. Lowrance WT, Elkin EB, Jacks LM, Yee DS, Jang TL, Laudone VP, Guillonneau BD, Scardino PT, Eastham JA (2010) Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes. J Urol 183(4): 1366-1372.
16. Hu JC, Gu X, Lipsitz SR, Barry MJ, D'Amico AV, Weinberg AC, Keating NL (2009) Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA 302: 1557-1564.
17. Hoffman A, Montgomery R, Aubry W, Tunis SR (2010) How best to engage patients, doctors, and other stakeholders in designing comparative effectiveness studies. Health Aff 29(10): 1834-1841.
18. Avorn J, Fischer M (2010) 'Bench to behavior': translating comparative effectiveness research into improved clinical practice. Health Aff 29(10): 1891-1900.
19. Shah ND, Mullan RJ, Breslin M, Yawn BP, Ting HH, Montori VM (2010) Translating comparative effectiveness into practice: the case of diabetes medications. Med Care 48(6 Suppl): S153-S158.
20. Garber AM, Tunis SR (2009) Does comparative-effectiveness research threaten personalized medicine? N Engl J Med 360(19): 1925-1927.